NYLIM
OFIX icon

New York Life Investment Management’s Orthofix Medical OFIX Stock Holding History

New York Life Investment Management’s Portfolio OFIX Stock Details OFIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-26,181
Closed -$380K – 1175
2024
Q1 		$380K Buy
26,181
+5,404
+26% +$74.7K ﹤0.01% 844
2023
Q4 		$280K Sell
20,777
-479
-2% -$5.63K ﹤0.01% 1242
2023
Q3 		$273K Sell
21,256
-3,349
-14% -$60.3K ﹤0.01% 1208
2023
Q2 		$444K Sell
24,605
-5,504
-18% -$103K ﹤0.01% 825
2023
Q1 		$504K Buy
30,109
+12,759
+74% +$250K 0.01% 668
2022
Q4 		$356K Buy
17,350
+1,956
+13% +$34.5K ﹤0.01% 1089
2022
Q3 		$294K Buy
15,394
+1,133
+8% +$25.5K ﹤0.01% 1113
2022
Q2 		$336K Buy
+14,261
New +$408K ﹤0.01% 1108

Other funds holding OFIX

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
ECM
Engine Capital Management New York $828M AUM 6.49% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
NM
Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return
GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

New York Life Investment Management's OFIX Position: Q2 2024 in Review

New York Life Investment Management sold out of Orthofix Medical (OFIX) in Q2 2024, closing a stake of 26,181 shares — an estimated $380K sold.

New York Life Investment Management first reported a position in OFIX in Q2 2022 and held it in 8 quarters. The position peaked at $504K in Q1 2023. 130 funds tracked by Wall St. Rank hold OFIX as of Q2 2024.

  • New York Life Investment Management reported no remaining Orthofix Medical position as of Q2 2024 after selling out during the quarter.
  • New York Life Investment Management sold 26,181 Orthofix Medical shares in Q2 2024, an estimated $380K.
  • New York Life Investment Management first reported a position in Orthofix Medical in Q2 2022 and held it in 8 quarters.
  • New York Life Investment Management's Orthofix Medical position peaked at $504K in Q1 2023.
  • 130 funds tracked by Wall St. Rank held Orthofix Medical as of Q2 2024.

Based on New York Life Investment Management's 13F filing for Q2 2024, filed 5 Aug 2024.